InvestorsHub Logo
Followers 137
Posts 22855
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 04/27/2019 9:52:15 AM

Saturday, April 27, 2019 9:52:15 AM

Post# of 61

stem cell researcher Reneuron up 22% due to positive clinical trials for a blindness treatment. That brought year-to-date returns to 520% making it the second largest riser in the FTSE Aim All Share Index this year, just behind 541.7% returns from MX Oil, according to Bloomberg data



https://portfolio-adviser.com/woodford-backed-stem-cell-company-rallies-520/

Good luck and GOD bless,